Hawaii SR 4: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Status: The committee on HHS deferred the measure. (as of 2025-03-24)

State: Hawaii · Session: 2025 · Bill: SR 4

Subjects: Auditor, Health, Insurance, Ketamine Therapy, Medicaid, Report

Sponsors: FEVELLA

View Hawaii SR 4 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.